Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Number of holders
-
171
-
Total 13F shares, excl. options
-
24,031,769
-
Shares change
-
-173,085
-
Total reported value, excl. options
-
$1,711,934,785
-
Value change
-
-$21,143,954
-
Put/Call ratio
-
131%
-
Number of buys
-
66
-
Number of sells
-
-105
-
Price
-
$71.25
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q3 2020
225 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2020.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,031,769 shares
of 48,932,355 outstanding shares and own 49% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2,588,911 shares), BlackRock Inc. (2,263,759 shares), RA CAPITAL MANAGEMENT, L.P. (2,035,132 shares), IRIDIAN ASSET MANAGEMENT LLC/CT (1,722,823 shares), RTW INVESTMENTS, LP (1,670,938 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,048,985 shares), ALETHEA CAPITAL MANAGEMENT, LLC (1,009,131 shares), BAKER BROS. ADVISORS LP (959,757 shares), PICTET ASSET MANAGEMENT LTD (890,559 shares), and STATE STREET CORP (653,934 shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.